Reuters: Regulatory News: European watchdog starts safety review of Merck cholesterol drug

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

European watchdog starts safety review of Merck cholesterol drug Dec 21st 2012, 11:04 LONDON | Fri Dec 21, 2012 6:04am EST LONDON Dec 21 (Reuters) - The European Medicines Agency said it has launched a review of Merck & Co Inc's cholesterol drug Tredaptive after the medicine failed in a large-scale study. The drug, already approved for use in Europe but not in the United States, is designed to raise "good" HDL cholesterol but the 25,000 patient study found it didn't do better at preventing heart attacks, deaths or strokes than traditional statin drugs that lower "bad" LDL cholesterol.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions